Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)

Clinical trial NCT03695510 · COMPLETED

Trial details

NCT number: NCT03695510
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2019-01-24
Primary completion: 2022-04-14
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.